Michael Barbella, Managing Editor04.07.22
Resonant Link is $9.3 million richer these days, thanks to a funding round led by The Engine, an MIT spun-out venture firm that invests in early-stage tough tech companies.
Other contributors to Resonant Link's financial windfall were Volta Energy Technologies (a new investor), and pre-seed investors Emerson Collective, Scout Ventures, Urban Us, and FreshTracks Capital. The money will be used for strategic hiring and to support product development and customer deployment. This growth will accelerate Resonant Link’s intent to bring wireless power to every medical device to eliminate drivelines and battery replacement surgeries, and to support electrification in industrial automotive fleets through wireless charging that delivers 24/7 uptime with smaller batteries.
Resonant Link is building best-in-class wireless chargers to power implantable medical devices and accelerate electrification in robotics, material handling, and electric vehicles. Its powerful multi-layer self-resonant structure (MSRS) enables wireless chargers that are:
“Energy and power have become the new vectors of competition across industry as consumers and patients demand better, safer and more mobile experiences,” said Dr. Grayson Zulauf, co-founder and CEO of Resonant Link. “Our technology isn’t just an evolution in wireless charging. By fundamentally changing the wireless coil geometry from two to three dimensions, we enable charging speeds equal to and faster than wired, longer ranges, smaller chargers, and radically reduced on-board battery sizes. This smaller battery footprint and longer operating life results in less obtrusive medical implants and less stops and more miles for industrial fleets.”
Resonant Link’s MSRS enables 99 percent efficient wireless links and supports medical implant depths up to six times deeper than current technology while meeting U.S. Food and Drug Administration-mandated temperature limits for devices such as pacemakers, neurostimulators, and ventricular assist devices (VADs). Tethering medical devices with wires and accessing them to charge is either not possible or is an unattractive and dangerous option for patients. Conventional wireless power coils can’t fundamentally deliver the efficiency, biocompatibility, tight integration, large gaps, and tiny size requirements. Resonant Link solves this challenge with the MSRS coil and their power electronics technology for 20 times higher recharge rates, simpler alignment for patients, and smaller devices—all at once.
Resonant Link was founded in 2017. Its growing team is a mix of former early-stage founders, engineers, and industry veterans from Tesla, Apple, Motiv, and Dynapower. The company is headquartered in Vermont, has employees in Massachusetts, California, and Zurich (Switzerland), and plans to expand in all three locations this year. Currently, seven medical partners are designing Resonant Link wireless power into their implantable devices.
“Resonant Link’s focus on medical and transportation applications shows how vast the potential reach is for their technology,” said Orin Hoffman, Partner at The Engine. “Mobility is becoming standard to nearly every consumer electronic device that requires power. Resonant Link is bringing mobility to the most essential, and most challenging, devices. I believe they have the ability to positively impact and improve future medical devices and transportation infrastructure.”
Resonant Link partners with the U.S. Air Force, U.S. Army, Activate/Cyclotron Road, U.S. Department of Defense, the TomKat Center for Sustainable Energy at Stanford University, National Science Foundation, Shell NREL GCxN Gamechanger, and Dartmouth College.
The Engine is a Cambridge, Mass.-based venture capital firm. It was conceived and created by MIT in 2016 to address the unmet need for sustained support for startups with the potential to solve complex, existential challenges and make a material, positive impact on society.
Other contributors to Resonant Link's financial windfall were Volta Energy Technologies (a new investor), and pre-seed investors Emerson Collective, Scout Ventures, Urban Us, and FreshTracks Capital. The money will be used for strategic hiring and to support product development and customer deployment. This growth will accelerate Resonant Link’s intent to bring wireless power to every medical device to eliminate drivelines and battery replacement surgeries, and to support electrification in industrial automotive fleets through wireless charging that delivers 24/7 uptime with smaller batteries.
Resonant Link is building best-in-class wireless chargers to power implantable medical devices and accelerate electrification in robotics, material handling, and electric vehicles. Its powerful multi-layer self-resonant structure (MSRS) enables wireless chargers that are:
- Five to 10 times higher performance than is possible with existing technologies
- Five to 10 times faster charge (speed)
- Four times lower in normalized costs
- Three times lighter in weight
- Three times smaller in size
“Energy and power have become the new vectors of competition across industry as consumers and patients demand better, safer and more mobile experiences,” said Dr. Grayson Zulauf, co-founder and CEO of Resonant Link. “Our technology isn’t just an evolution in wireless charging. By fundamentally changing the wireless coil geometry from two to three dimensions, we enable charging speeds equal to and faster than wired, longer ranges, smaller chargers, and radically reduced on-board battery sizes. This smaller battery footprint and longer operating life results in less obtrusive medical implants and less stops and more miles for industrial fleets.”
Resonant Link’s MSRS enables 99 percent efficient wireless links and supports medical implant depths up to six times deeper than current technology while meeting U.S. Food and Drug Administration-mandated temperature limits for devices such as pacemakers, neurostimulators, and ventricular assist devices (VADs). Tethering medical devices with wires and accessing them to charge is either not possible or is an unattractive and dangerous option for patients. Conventional wireless power coils can’t fundamentally deliver the efficiency, biocompatibility, tight integration, large gaps, and tiny size requirements. Resonant Link solves this challenge with the MSRS coil and their power electronics technology for 20 times higher recharge rates, simpler alignment for patients, and smaller devices—all at once.
Resonant Link was founded in 2017. Its growing team is a mix of former early-stage founders, engineers, and industry veterans from Tesla, Apple, Motiv, and Dynapower. The company is headquartered in Vermont, has employees in Massachusetts, California, and Zurich (Switzerland), and plans to expand in all three locations this year. Currently, seven medical partners are designing Resonant Link wireless power into their implantable devices.
“Resonant Link’s focus on medical and transportation applications shows how vast the potential reach is for their technology,” said Orin Hoffman, Partner at The Engine. “Mobility is becoming standard to nearly every consumer electronic device that requires power. Resonant Link is bringing mobility to the most essential, and most challenging, devices. I believe they have the ability to positively impact and improve future medical devices and transportation infrastructure.”
Resonant Link partners with the U.S. Air Force, U.S. Army, Activate/Cyclotron Road, U.S. Department of Defense, the TomKat Center for Sustainable Energy at Stanford University, National Science Foundation, Shell NREL GCxN Gamechanger, and Dartmouth College.
The Engine is a Cambridge, Mass.-based venture capital firm. It was conceived and created by MIT in 2016 to address the unmet need for sustained support for startups with the potential to solve complex, existential challenges and make a material, positive impact on society.
